APCCC 2024: Hot Flushes – How Can We Help Our Patients?
APCCC 2024, prostate cancer, Hot Flushes, Hot Flushes from prostate cancer treatment, management of Hot Flushes, therapy recommendations for addressing hot flushes, PATCH trial.
APCCC 2024, prostate cancer, Hot Flushes, Hot Flushes from prostate cancer treatment, management of Hot Flushes, therapy recommendations for addressing hot flushes, PATCH trial.
Sam Chang leads a discussion with Ashish Kamat and Matt Galsky on their co-authored article, focusing on new trial parameters for urothelial carcinoma. This collaboration,…
From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.
Sandoz is no longer cooperating with a U.K. industry trade group following a dispute over allegations that the company inappropriately marketed a biosimilar medicine.
FDA warned consumers against using Cue Health’s COVID-19 tests as it might lead to false results.
The U.S. Department of Justice recently launched a task force on healthcare monopolies. Experts have varying opinions on how it will impact the healthcare industry.
Andrea Miyahira interviews Mayuko Kanayama about her team’s research on a HOXB13 variant linked to aggressive prostate cancer in African ancestry populations. Published in European…
Experience with vaccination against SARS-CoV-2 has shown that it reduces susceptibility to the virus, but breakthrough infections can occur. Important questions remain about the characteristics…
Combining biomedical finesse and nature-inspired engineering, a uOttawa-led team of scientists has created a jelly-like material that shows great potential for on-the-spot repair to a…
Johns Hopkins Medicine researchers say they have found that specific variations in three genes related to maintaining the length of telomeres—the protective DNA endcaps on…
Adam Feuerstein’s brand-new weekly email newsletter offers exclusive biotech coverage for STAT+ subscribers. Sign up today!